Supernus Pharmaceuticals, Inc. (SUPN)
45.11
-0.74
(-1.61%)
USD |
NASDAQ |
Aug 24, 16:00
45.11
0.00 (0.00%)
After-Hours: 20:00
Supernus Pharmaceuticals Profit Margin (Quarterly) : -26.65% for June 30, 2026
Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -26.65% |
| March 31, 2026 | -1.10% |
| December 31, 2025 | -1.94% |
| September 30, 2025 | -23.49% |
| June 30, 2025 | 13.60% |
| March 31, 2025 | -7.89% |
| December 31, 2024 | 8.80% |
| September 30, 2024 | 21.91% |
| June 30, 2024 | 11.83% |
| March 31, 2024 | 0.09% |
| December 31, 2023 | 0.72% |
| September 30, 2023 | -10.38% |
| June 30, 2023 | -0.61% |
| March 31, 2023 | 11.02% |
| December 31, 2022 | 15.23% |
| September 30, 2022 | 0.99% |
| June 30, 2022 | 4.63% |
| March 31, 2022 | 16.80% |
| December 31, 2021 | 1.54% |
| September 30, 2021 | 14.52% |
| June 30, 2021 | 16.79% |
| March 31, 2021 | 4.35% |
| December 31, 2020 | 21.43% |
| September 30, 2020 | 25.78% |
| June 30, 2020 | 27.36% |
| Date | Value |
|---|---|
| March 31, 2020 | 22.66% |
| December 31, 2019 | 32.98% |
| September 30, 2019 | 28.26% |
| June 30, 2019 | 31.26% |
| March 31, 2019 | 21.46% |
| December 31, 2018 | 22.33% |
| September 30, 2018 | 27.20% |
| June 30, 2018 | 30.88% |
| March 31, 2018 | 29.14% |
| December 31, 2017 | 15.44% |
| September 30, 2017 | 19.85% |
| June 30, 2017 | 22.90% |
| March 31, 2017 | 17.88% |
| December 31, 2016 | 22.96% |
| September 30, 2016 | |
| June 30, 2016 | 19.86% |
| March 31, 2016 | 10.92% |
| December 31, 2015 | 15.68% |
| September 30, 2015 | 10.94% |
| June 30, 2015 | 6.83% |
| March 31, 2015 | 2.57% |
| December 31, 2014 | 14.14% |
| September 30, 2014 | 53.08% |
| June 30, 2014 | 10.79% |
| March 31, 2014 | -171.2% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Indivior Pharmaceuticals, Inc. | 35.57% |
| Pfizer Inc. | -1.64% |
| Amphastar Pharmaceuticals, Inc. | 16.50% |
| Collegium Pharmaceutical, Inc. | -7.53% |
| Bristol Myers Squibb Co. | 25.54% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -10.40% |
| Return on Assets | -7.48% |
| Return on Invested Capital | -10.03% |
| Gross Profit Margin (Quarterly) | 72.88% |
| Operating Margin (Quarterly) | -2.49% |
| Return on Net Operating Assets | -11.54% |